Concepedia
Statistics
Publications
64
Citations
6K
H-Index
34
Active since
2004
Affiliations
George Mason University(Current)
University of North Carolina at Chapel Hill
Translational Genomics Research Institute
Centro di Riferimento Oncologico
Istituti di Ricovero e Cura a Carattere Scientifico
Mariaelena Pierobon is an author at George Mason University specializing in oncology, medicine, and molecular oncology.
Publications per year
2004–2024
The KRASG12C Inhibitor MRTX849 Provides Insight toward Therapeutic Susceptibility of KRAS-Mutant Cancers in Mouse Models and Patients
Jill Hallin, Lars D. Engstrom, Lauren Hargis et al. · Cancer Discovery · 2019 · 1.3K citations · Full text
Medicine, Oncology, Pharmacology +17
Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer
Kirsten L. Bryant, Clint A. Stalnecker, Daniel Zeitouni et al. · Nature Medicine · 2019 · 715 citations
Life Sciences, Cell Biology, Oncology +16
Combined BRAF and MEK Inhibition With Dabrafenib and Trametinib in <i>BRAF</i> V600–Mutant Colorectal Cancer
Ryan B. Corcoran, Chloé E. Atreya, Gerald S. Falchook et al. · Journal of Clinical Oncology · 2015 · 512 citations · Full text
Long-Term ERK Inhibition in KRAS-Mutant Pancreatic Cancer Is Associated with MYC Degradation and Senescence-like Growth Suppression
Tikvah K. Hayes, Nicole F. Neel, Chaoxin Hu et al. · Cancer Cell · 2015 · 275 citations · Full text
Medicine, Cancer Biology, Oncology +17
Atypical KRASG12R Mutant Is Impaired in PI3K Signaling and Macropinocytosis in Pancreatic Cancer
G. Aaron Hobbs, Nicole M. Baker, Anne M. Miermont et al. · Cancer Discovery · 2019 · 226 citations · Full text
Medicine, Genetics, Oncology +12
1–5 of 64